Personal profile
Fingerprint
Dive into the research topics where Akinao Okamoto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical characteristics of monoclonal immunoglobulin-associated renal disease: a retrospective cohort study
Narimiya, T., Hayashi, H., Ogata, S., Hara, S., Okamoto, A., Takahashi, K., Koide, S., Inaguma, D., Hasegawa, M., Tomita, A., Yuzawa, Y. & Tsuboi, N., 03-2025, In: Clinical and Experimental Nephrology. 29, 3, p. 259-268 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
ELC52: a novel megakaryocytic leukemia cell line with a CALR type 1 mutation
Yamamoto, Y., Iba, S., Inaguma, Y., Okamoto, A. & Abe, A., 01-2025, In: Leukemia. 39, 1, p. 234-237 4 p.Research output: Contribution to journal › Letter › peer-review
-
Prognostic relevance of early clinical and laboratory findings in immune-mediated thrombotic thrombocytopenic purpura
Hamamura, A., Sakai, K., Mushino, T., Ueda, Y., Ogawa, Y., Noguchi, H., Okamoto, A., Yagi, H., Mori, T. & Matsumoto, M., 07-2025, In: Research and Practice in Thrombosis and Haemostasis. 9, 5, 102974.Research output: Contribution to journal › Article › peer-review
Open Access -
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trial
Shimada, K., Yamaguchi, M., Kuwatsuka, Y., Matsue, K., Sato, K., Kusumoto, S., Nagai, H., Takizawa, J., Fukuhara, N., Nagafuji, K., Miyazaki, K., Ohtsuka, E., Okamoto, A., Sugita, Y., Uchida, T., Kayukawa, S., Wake, A., Ennishi, D., Kondo, Y. & Meguro, A. & 12 others, , 02-2025, In: EClinicalMedicine. 80, 103078.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Citations (Scopus) -
Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era
Okamoto, A., Yoshida, M., Kasahara, S., Ara, T., Ozeki, K., Morishita, T., Ikeda, D., Kanaya, M., Kajiguchi, T., Suzuki, Y., Kurahashi, S., Horio, T., Marumo, Y., Oyake, T., Saito, S., Sawa, H., Kimura, S. I., Nishiyama, T., Kondo, E. & Hiraga, J. & 10 others, , 2025, In: Frontiers in Oncology. 15, 1687204.Research output: Contribution to journal › Article › peer-review
Open Access